Skip to main content
Log in

Use of methylphenidate in the treatment of children with autistic disorder

  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

The use of psychostimulants in autistic disorder has not received extensive evaluation. Furthermore, their use for the symptomatic control of autistic disorder has been felt to be contraindicated. This study investigates the use of methylphenidate (MPH) for the treatment of selected symptoms of autistic disorder. Ten children, ages 7–11, with a DSM-III-R diagnosis of autistic disorder participated in a double-blind crossover study using placebo and two MPH doses (10 mg or 20 mg bid). Subjects showed modest but statistically significant improvement on MPH over placebo. No significant side effects including worsening stereotypic movements occurred on either dose. Improvement in hyperactivity and lack of adverse effects suggest that MPH may be useful in the treatment of hyperactive autistic children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aman, M. (1988). The use of methylphenidate in autism [Letter to the editor].Journal of the American Academy of Child and Adolescent Psychiatry, 27, 821–822.

    PubMed  Google Scholar 

  • Aman, M., & Singh, N. N. (1985). The Aberrant Behavior Checklist.Psychopharmacological Bulletin, 21, 845–850.

    Google Scholar 

  • American Psychiatric Association. (1968).Diagnostic and statistical manual of mental disorders (2nd ed.). Washington, DC: Author.

    Google Scholar 

  • American Psychiatric Association. (1980).Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.

    Google Scholar 

  • American Psychiatric Association (1987).Diagnostic and statistical manual of mental disorders (3rd ed., rev). Washington, DC: author.

    Google Scholar 

  • Anderson, L., Campbell, M., Grega, D., et al. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms.American Journal of Psychiatry, 141, 1195–1202.

    PubMed  Google Scholar 

  • Anderson, L. T., Campbell, M., Adams, P., Small, A. M., Perry, R., & Small, J. (1989). The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.Journal of Autism and Developmental Disorders, 19, 227–239.

    PubMed  Google Scholar 

  • Barkley, R. A., DuPaul, G. J., & McMurray, M. B. (1991). Attention deficit disorder with and without hyperactivity: Clinical response to 3 dose levels of methylphenidate.Pediatrics, 87, 519–531.

    PubMed  Google Scholar 

  • Birmaher, B., Quintana, H., & Greenhill, L. (1988). Methylphenidate treatment of hyperactive autistic children.Journal of the American Academy of Child and Adolescent Psychiatry, 27, 248–251.

    PubMed  Google Scholar 

  • Campbell, M., Adams, P., Perry, R., Spencer, E. K., & Overall, J. E. (1988). Tardive and withdrawal dyskinesia in autistic children: A prospective study.Psychopharmacology Bulletin, 24, 251–255.

    PubMed  Google Scholar 

  • Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., & Green, W. H. (1978). A comparison of haloperidol, behavior therapy, and their interactions in autistic children.Journal of the American Academy of Child Psychiatry, 17, 640–655.

    PubMed  Google Scholar 

  • Campbell, M., Anderson, L., Small, A., Adams, P., Gonzalez, N., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral Symptoms and Attentional Learning.Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283–1291.

    PubMed  Google Scholar 

  • Campbell, M., Anderson, L., Small, A., et al. (1990). Naltrexone in autistic children: A double-blind and placebo controlled study.Psychopharmacological Bulletin, 26, 130–135.

    Google Scholar 

  • Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., & Koch, C. (1972). Response to triiodothyronine and dextroamphetamine: A study of preschool, schizophrenic children.Journal of Autism and Childhood Schizophrenia, 2, 343–358.

    PubMed  Google Scholar 

  • Campbell, M., Geller, B., & Cohen, I. L. (1977). Current status of drug research and treatment in autistic children.Journal of Pediatric Psychology, 2, 153–161.

    Google Scholar 

  • Campbell, M., Gonzalez, N. M., Ernst, M., et al. (1993). Neuroleptics. In J. S. Werry & M. G. Aman (Eds.),Practitioners guide to psychoactive drugs for children and adolescents (pp. 269–296). New York: Plenum Press.

    Google Scholar 

  • Campbell, M., & Green, W. H. (1985). Pervasive developmental disorders of childhood. In H. I. Kaplan & B. J. Sadock (Eds.),Comprehensive textbook of psychiatry (Vol. 4, 4th ed., pp. 1672–1683).

  • Conners, C. K. (1973). Rating scales for use in drug studies with children. [Special issue]Psychopharmacological Bulletin, 9, 24–42.

    Google Scholar 

  • Gelfand, R. (1980). Glossary. In H. I. Kaplan, A. M. Freedman, & B. Sadock (Eds.),Comprehensive textbook of psychiatry (Vol. 3, 3rd ed., p. 3334). Baltimore: Williams & Wilkins.

    Google Scholar 

  • Geller, B., Guttmacher, L., & Bleeg, M. (1981). Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity.American Journal of Psychiatry, 138, 388–389.

    PubMed  Google Scholar 

  • Gordon, C. T., State, R. C., Nelson, J. E. et al. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.Archives of General Psychiatry, 50, 441–447.

    PubMed  Google Scholar 

  • Goyette, C., Conners, C. K., & Sulrick, R. F. (1978). Normative data on revised Conners parent and teacher ratings scales.Journal of Abnormal Child Psychology, 6, 221–230.

    PubMed  Google Scholar 

  • Gualtieri, C. T., Barnhill, J., McGinsey, J., et al. (1980). Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs.Journal of the American Academy of Child Psychiatry, 19, 491–510.

    PubMed  Google Scholar 

  • Gualtieri, C. T., Quade, D., Hicks, R. D., et al. (1984). Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.American Journal of Psychiatry, 141, 20–23.

    PubMed  Google Scholar 

  • Guy, W. (1976).ECDEU assessment manual of psychopharmacology. Rockville, MD: NIMH Psychopharmacology Research Branch.

    Google Scholar 

  • Hoshino, Y., Kumashiro, H., Kanero, M., & Takahashi, Y. (1977). The effects of methylphenidate in early infantile autism and its relation to serum serotonin levels.Folia Psyciatrica et Neurologica Japonica, 31, 605–614.

    Google Scholar 

  • Keepers, G. A., Clappison, V. J., & Casey, D. E. (1983). Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes.Archives of General Psychiatry, 40, 1113–1117.

    PubMed  Google Scholar 

  • McDougle, C. L., Price, L. H., Volkmar, F. R. et al. (1992). Clomipramine in autism: Preliminary evidence of efficacy.Journal of Academy of Child and Adolescent Psychiatry, 31, 746–750.

    Google Scholar 

  • Perry, R., Campbell, M., Adams, P., et al. (1989). A multidimensional long term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration.Journal of American Academy of Child and Adolescent Psychiatry, 28, 87–92.

    Google Scholar 

  • Perry, R., Campbell, M., Green, W., Small, A., & Trill, M. (1985). Neuroleptic related dyskinesias in autistic children: A prospective study.Psychopharmacology Bulletin, 21, 140–143.

    PubMed  Google Scholar 

  • Schopler, E., Reichler, R. J., & Renner, B. (1985). Childhood Autism Rating Scale (CARS).Psychopharmacology Bulletin, 21, 1052–1053.

    Google Scholar 

  • Schopler, E., Reichler, R. J., & Renner, B. (1988).Childhood Autism Rating Scale (CARS). Los Angeles: Western Psychological Services.

    Google Scholar 

  • Sloman, L. (1991). Use of medications in pervasive developmental disorders.Psychiatric Clinics of North America, 14, 165–182.

    PubMed  Google Scholar 

  • Strayhorn, J. M., Rapp, N., Donina, W., & Strain, P. S. (1988). Randomized trial of methylphenidate for an autistic child.Journal of the American Academy of Child and Adolescent Psychiatry, 27, 244–247.

    PubMed  Google Scholar 

  • Vitriol, C., & Farber, B. (1981). Stimulant medication in certain childhood disorders.American Journal of Psychiatry, 138, 1517–1518.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Formerly at New York State Psychiatric Institute.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quintana, H., Birmaher, B., Stedge, D. et al. Use of methylphenidate in the treatment of children with autistic disorder. J Autism Dev Disord 25, 283–294 (1995). https://doi.org/10.1007/BF02179289

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02179289

Keywords

Navigation